figshare
Browse
1/3
47 files

Supplemental Files for "Influenza A Virus Field Surveillance at a Swine-Human Interface" published by mSphere.

Download all (11.8 MB) This item is shared privately
figure
modified on 2020-02-18, 14:09

Abstract

Working overnight at a swine exhibition, we identified an influenza A virus (IAV) outbreak in swine, nanopore-sequenced 13 IAV genomes from samples collected, and in real-time predicated that these viruses posed a novel risk to humans due to genetic mismatches between the viruses and current pre-pandemic candidate vaccine viruses (CVV). We developed and used a portable IAV sequencing and analysis platform called Mia (Mobile Influenza Analysis) to complete and characterize full-length consensus genomes approximately 18 hours after unpacking the mobile lab. Exhibition swine are a known source for zoonotic transmission of influenza A virus (IAV) to humans and pose a potential pandemic risk. Genomic analyses of IAV in swine are critical to understanding this risk, the types of viruses circulating in swine, and whether current vaccines developed for use in humans would be predicted to provide immune protection. Nanopore sequencing technology has enabled genome sequencing in the field at the source of viral outbreaks or at the bedside or pen-side of infected humans and animals. The acquired data, however, has not yet demonstrated real-time, actionable public health responses. The Mia system rapidly identified three genetically distinct swine IAV lineages from three subtypes: A(H1N1), A(H3N2) and A(H1N2). Analysis of the HA protein sequences of the A(H1N2) viruses identified >30 amino acid differences between the HA1 portion of the hemagglutinin of these viruses and the most closely related pre-2009 CVV. As an exercise in pandemic preparedness, all sequences were emailed to CDC collaborators who initiated development of a synthetically derived CVV.

Funding

Research reported in this publication was supported by the office of Advanced Molecular Detection (AMD CAN 939018 C) at the Centers for Disease Control and Prevention. The Council of State and Territorial Epidemiologists supported this project with funds provided by the Centers for Disease Control and Prevention under Cooperative Agreement No. 5U38OT000143-05. Nasal wipes were collected as part of influenza A virus surveillance supported by the Centers of Excellence for Influenza Research and Surveillance, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services contract HHSN272201400006C